Investors’ appetites whetted by alternative proteins

Cell-cultured meat, plant-based foie gras, algae milk and seaweed caviar are just some of the increasingly sophisticated alternative protein options flooding the market—and whetting investors’ appetites. Last year alone, dozens of companies were launched, and many are attracting big investors, according to the burgeoning industry’s pioneers. “For every company that’s looking for money, there are two or three investors. I’ve […]

Read more

Sex and aggression in mice controlled by cold-sensor in brain

Testosterone is blamed for sex drive and aggression, but it also appears to be critical for telling the brain “enough!” when it comes to those behaviors. A molecule called TRPM8 (pronounced trip-M-8) embedded in the surface of some cells seems to be responsible for sending these cues in response to testosterone. Without these cues, male mice become dangerously aggressive and […]

Read more

Blueberries may lower cardiovascular risk by up to 20 percent

Dubbed “the silent killer” because it has no visible symptoms in its early stages, hypertension affects approximately 1 in 3 adults in the United States. The condition puts a strain on the cardiovascular system, which in the long run may contribute to heart failure, stroke, and kidney failure. The National Institutes of Health (NIH) recommend that people with high blood […]

Read more

AI Technology IDs Genetic Diseases by Analyzing Facial Photos

TUESDAY, Jan. 8, 2019 — Certain genetic diseases can be detected by new artificial intelligence technology that analyzes a photo of a person’s face, according to a study published online Jan. 7 in Nature Medicine. The DeepGestalt technology was better than doctors at identifying a range of genetic syndromes, CNN reported. Examples of conditions that can be identified by the […]

Read more

Lynparza (olaparib) Approved by US FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer

19 December 2018 — AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the US and Canada) today announced that the US Food and Drug Administration (FDA) has approved Lynparza for use as maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced epithelial ovarian, fallopian tube or primary peritoneal […]

Read more

Impact of opioid epidemic on children varies by state

A new report released by the Drug Enforcement Administration finds most overdose deaths are caused by prescription drugs, including opioids. While opioid abuse continues to plague certain states more than others, each state is unique in how it attempts to stem the crisis and its effect on families. These differences have resulted in significant variation across the country between opioid […]

Read more

Removal of the Appendix reduces the risk of Parkinson’s disease by 20%

According to new research, after the removal of the Appendix, almost 20% reduced chance of developing Parkinson’s disease. To such conclusion scientists have come, having analysed the data of 1.6 million. The results of their study were published in the journal Science Translational Medicine. Parkinson’s disease is a common disorder. And therefore, most likely, she may have a few points […]

Read more